Collegium Pharmaceutical
COLL
227 hedge funds and large institutions have $1.54B invested in Collegium Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 78 increasing their positions, 78 reducing their positions, and 16 closing their positions.
453% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $601K
219% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 16
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
27% more capital invested
Capital invested by funds: $1.21B → $1.54B (+$331M)
18% more funds holding
Funds holding: 193 → 227 (+34)
3.79% more ownership
Funds ownership: 120.27% → 124.05% (+3.8%)
0% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 78
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$33.9M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$14.4M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$8.7M |
| 4 |
Man Group
London,
United Kingdom
|
+$7.17M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$32.3M |
| 2 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$10.6M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$9.62M |
| 4 |
Millennium Management
New York
|
-$8.76M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$6.9M |
COLL Hedge Fund Activity: Q1 2024 in Review
227 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2024, worth a combined $1.54B — up 27% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new COLL positions and 16 closed out — a net gain of 35 holders — while 78 added to existing stakes and 78 trimmed.
The largest buyer was Fuller & Thaler Asset Management, opening a new position worth an estimated $33.9M. The largest seller was Rubric Capital Management (New York), cutting an estimated $32.3M.
- 227 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2024, up from 193 in Q4 2023.
- Funds reported $1.54B of Collegium Pharmaceutical stock for Q1 2024, up 27% quarter-over-quarter.
- 51 funds opened new Collegium Pharmaceutical positions in Q1 2024 and 16 closed out, a net change of +35 holders.
- The largest Collegium Pharmaceutical buyer in Q1 2024 was Fuller & Thaler Asset Management, an estimated $33.9M added.
- The largest Collegium Pharmaceutical seller in Q1 2024 was Rubric Capital Management (New York), an estimated $32.3M sold.
Based on aggregated 13F filings for Q1 2024.